Top

CardioVascular and Interventional Radiology

Published in:

01-01-2009 | Laboratory Investigation

FDG-MicroPET and Diffusion-Weighted MR Image Evaluation of Early Changes After Radiofrequency Ablation in Implanted VX2 Tumors in Rabbits

Authors: Tomohiro Ohira, Tomohisa Okuma, Toshiyuki Matsuoka, Yasuhiro Wada, Kenji Nakamura, Yasuyoshi Watanabe, Yuichi Inoue

Published in: CardioVascular and Interventional Radiology | Issue 1/2009

Abstract

The objective of this study was to evaluate the early changes after radiofrequency ablation (RFA) in VX2 rabbit tumors implanted into the back muscles by diffusion-weighted magnetic resonance (MR) imaging and ¹⁸F-2-fluoro-2-deoxy-D-glucose positron emission tomography (¹⁸F-FDG PET). Percutaneous CT-guided RFA was conducted in seven rabbits with implanted VX2 tumors. VX2 tumors on the other side were untreated and served as the control. MR imaging was performed with a clinical 1.5-T instrument 2 days after RFA, and FDG-PET, using a high-resolution PET scanner for small animals, was obtained 3 days after the procedure. The mean apparent diffusion coefficient (ADC) values and radioactivity count of untreated and ablated tumors were calculated. Untreated VX2 tumors showed hyperintensity on T1-, T2-, and diffusion-weighted MR images, ring-enhanced on contrast-enhanced T1-weighted imaging, and ring-shaped FDG accumulation on FDG-PET. Ablated VX2 tumors showed slight hyperintensity on T1-, T2-, and diffusion-weighed images, slight enhancement on contrast-enhanced T1-weighted images, and low accumulation on FDG-PET. The ADC value of ablated VX2 tumors (1.52 ± 0.24 × 10⁻³ mm²/s) was significantly higher than that of untreated tumors (1.09 ± 0.12 × 10⁻³; p < 0.05). The tumor/muscle ratio of ablated tumors (0.5 ± 0.3) was significantly lower than that of untreated tumors (11.6 ± 3.2; p < 0.05). Histopathological examination confirmed the lack of viable tumor cells in the ablated lesions. The results indicate that both ADC value and FDG-PET are potentially useful markers for monitoring the early effects of RFA.

Gillams AR (2005) Image guided tumour ablation. Cancer Imaging 5:103–109PubMedCrossRef

Ni Y, Mulier S, Miao Y, Michel L, Marchal G (2005) A review of the general aspects of radiofrequency ablation. Abdom Imaging 30:381–400PubMedCrossRef

Dupuy DE, Goldberg SN (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities. Part 2. J Vasc Interv Radiol 12:1135–1148PubMedCrossRef

Gazelle GS, Goldberg SN, Solbiati L et al (2000) Tumor ablation with radiofrequency energy. Radiology 217:633–646PubMed

Rose SC, Thistlethwaite PA, Sewell PE et al (2006) Lung cancer and radiofrequency ablation. J Vasc Interv Radiol 17:927–951PubMedCrossRef

Galons JP, Altbach MI, Paine-Murrieta GD, Taylor CW, Gillies RJ (1999) Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia 1:113–117PubMedCrossRef

Theilmann RJ, Borders R, Trouard TP et al (2004) Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 6:831–837PubMedCrossRef

Jennings D, Hatton BN, Guo J et al (2002) Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. Neoplasia 4:255–262PubMedCrossRef

Roth Y, Tichler T, Kostenich G et al (2004) High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology 232:685–692PubMedCrossRef

10.

Tomura N, Narita K, Izumi J et al (2006) Diffusion changes in a tumor and peritumoral tissue after stereotactic irradiation for brain tumors: possible prediction of treatment response. J Comput Assist Tomogr 30:496–500PubMedCrossRef

11.

Thoeny HC, De Keyzer F, Chen F et al (2005) Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology 234:756–764PubMedCrossRef

12.

Geschwind JF, Artemov D, Abraham S et al (2000) Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J Vasc Interv Radiol 11:1245–1255PubMedCrossRef

13.

Baur A, Huber A, Arbogast S et al (2001) Diffusion-weighted imaging of tumor recurrencies and posttherapeutical soft-tissue changes in humans. Eur Radiol 11:828–833PubMedCrossRef

14.

Herneth AM, Guccione S, Bednarski M (2003) Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterization. Eur J Radiol 45:208–213PubMedCrossRef

15.

Deng J, Rhee TK, Sato KT et al (2006) In vivo diffusion-weighted imaging of liver tumor necrosis in the VX2 rabbit model at 1.5 Tesla. Invest Radiol 41:410–414PubMedCrossRef

16.

van Rijswijk CS, Kunz P, Hogendoorn PC, Taminiau AH, Doornbos J, Bloem JL (2002) Diffusion-weighted MRI in the characterization of soft-tissue tumors. J Magn Reson Imaging 15:302–307PubMedCrossRef

17.

Einarsdottir H, Karlsson M, Wejde J, Bauer HC (2004) Diffusion-weighted MRI of soft tissue tumours. Eur Radiol 14:959–963PubMedCrossRef

18.

Baur A, Reiser MF (2000) Diffusion-weighted imaging of the musculoskeletal system in humans. Skel Radiol 29:555–562CrossRef

19.

Dietrich O, Raya JG, Sommer J, Deimling M, Reiser MF, Baur-Melnyk A (2005) A comparative evaluation of a RARE-based single-shot pulse sequence for diffusion-weighted MRI of musculoskeletal soft-tissue tumors. Eur Radiol 15:772–783PubMedCrossRef

20.

Giannopoulou C (2003) The role of SPET and PET monitoring tumour response to therapy. Eur J Nucl Med 30:1173–1200CrossRef

21.

Anderson GS, Brinkmann F, Soulen MC, Alavi A, Zhuang H (2003) FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clin Nucl Med 28:192–197PubMedCrossRef

22.

Oya N, Nagata Y, Tamaki N et al (1996) FDG-PET evaluation of therapeutic effects on VX2 liver tumor. J Nucl Med 37:296–302PubMed

23.

Okuma T, Okamura T, Matsuoka T et al (2006) Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results. Ann Nucl Med 20:115–121PubMedCrossRef

24.

Okuma T, Matsuoka T, Okamura T et al (2006) ¹⁸F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J Nucl Med 47:1351–1358PubMed

25.

Kondo S, Hosono MN, Wada Y et al (2004) Use of FDG-microPET for detection of small nodules in a rabbit model of pulmonary metastatic cancer. Ann Nucl Med 18:51–57PubMedCrossRef

26.

Ishii K, Hosono MN, Wada Y et al (2006) Usefulness of FDG-microPET for early evaluation of therapeutic effects on VX2 rabbit carcinoma. Ann Nucl Med 20:123–130PubMedCrossRef

27.

Oyama Y, Nakamura K, Matsuoka T et al (2005) Radiofrequency ablated lesion in the normal porcine lung: long-term follow-up with MRI and pathology. CardioVasc Interv Radiol 28:346–353CrossRef

28.

Yuan YH, Xiao EH, Xiang J et al (2005) MR diffusion-weighted imaging of rabbit liver VX–2 tumor. World J Gastroenterol 11:3070–3074PubMed

Title: FDG-MicroPET and Diffusion-Weighted MR Image Evaluation of Early Changes After Radiofrequency Ablation in Implanted VX2 Tumors in Rabbits
Authors: Tomohiro Ohira
Tomohisa Okuma
Toshiyuki Matsuoka
Yasuhiro Wada
Kenji Nakamura
Yasuyoshi Watanabe
Yuichi Inoue
Publication date: 01-01-2009
Publisher: Springer-Verlag
Published in: CardioVascular and Interventional Radiology / Issue 1/2009
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-008-9394-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

FDG-MicroPET and Diffusion-Weighted MR Image Evaluation of Early Changes After Radiofrequency Ablation in Implanted VX2 Tumors in Rabbits

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2009

Histology of Tissue Adherent to OptEase Inferior Vena Cava Filters Regarding Indwelling Time

Malignant Gastroduodenal Obstruction: Treatment with Self-Expanding Uncovered Wallstent

Migration of Embolization Coils: Our Experience

Radiofrequency Ablation Assisted by Real-Time Virtual Sonography and CT for Hepatocellular Carcinoma Undetectable by Conventional Sonography

Acute Increase in Hepatic Arterial Flow During TIPS Identified by Intravascular Flow Measurements

Treatment of an Unusual Complication of Endovenous Laser Therapy: Multiple Small Arteriovenous Fistulas Causing Complete Recanalization